Cocaine- and opiate-related fatal overdose in New York City, 1990-2000

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Bernstein, Kyle T ^a   Bucciarelli, Angela ^b   Piper, Tinka Markham ^b   Gross, Charles ^c   Tardiff, Ken ^c   Galea, Sandro ^d,e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Mailman School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; OPIATE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; AUTOPSY; BUILDING; CLASSIFICATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG FATALITY; DRUG OVERDOSE; FEMALE; HISPANIC; HOME; HUMAN; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; RISK FACTOR; UNITED STATES; COCAINE DEPENDENCE; MIDDLE AGED; MORTALITY; OPIATE ADDICTION; STATISTICAL MODEL;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEW YORK CITY; OPIOID-RELATED DISORDERS;

EID: 34047144370     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-31     Document Type: Article

References (49)

1. "Alcohol dependence" and death: survival analysis of the Baltimore ECA sample from 1981 to 1995. YD Neumark ML Van Etten JC Anthony, Subst Use Misuse 2000 35 533 549 10741540
2. Mortality rates among opioid addicts in a longitudinal study. GW Joe DD Simpson, Am J Public Health 1987 77 347 348 3812844
3. Mortality and survival among a cohort of drug injectors in Glasgow, 1982-1994. M Frischer D Goldberg M Rahman L Berney, Addiction 1997 92 419 427 10.1111/j.1360-0443.1997.tb03373.x 9177063
4. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. E Oppenheimer C Tobutt C Taylor T Andrew, Addiction 1994 89 1299 1308 10.1111/j.1360-0443.1994.tb03309.x 7804091
5. Mortality of intravenous drug users in Rome: a cohort study. CA Perucci M Davoli E Rapiti DD Abeni F Forastiere, Am J Public Health 1991 81 1307 1310 1656799
6. Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. D Demetriades G Gkiokas GC Velmahos C Brown J Murray T Noguchi, J Am Coll Surg 2004 199 687 692 10.1016/j.jamcollsurg.2004. 07.017 15501107
7. Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. DK Smith LI Gardner R Phelps ME Hamburger C Carpenter RS Klein A Rompalo P Schuman SD Holmberg, J Urban Health 2003 80 676 688 14709715
8. Overdose deaths attributed to methadone and heroin in New York City, 1990-1998. WK Bryant S Galea M Tracy PT Markham KJ Tardiff D Vlahov, Addiction 2004 99 846 854 10.1111/j.1360-0443.2004.00693.x 15200580
9. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. PO Coffin S Galea J Ahern AC Leon D Vlahov K Tardiff, Addiction 2003 98 739 747 10.1046/j.1360-0443.2003.00376.x 12780362
10. Racial/ethnic disparities in overdose mortality trends in New York City, 1990-1998. S Galea J Ahern K Tardiff A Leon PO Coffin K Derr D Vlahov, J Urban Health 2003 80 201 211 12791796
11. Summary of Vital Statistics 2003. New York City Department of Health and Mental Hygiene, 2004
12. Heroin overdose deaths - Multnomah County, Oregon, 1993-1999. MMWR Morb Mortal Wkly Rep 2000 49 633 636 10926305
13. Unintentional opiate overdose deaths - King County, Washington, 1990-1999. MMWR Morb Mortal Wkly Rep 2000 49 636 640 10926306
14. Heroin-related deaths in New South Wales, Australia, 1992-1996. S Darke J Ross D Zador S Sunjic, Drug Alcohol Depend 2000 60 141 150 10.1016/S0376- 8716(99)00147-7 10940541
15. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. C McGregor S Darke R Ali P Christie, Addiction 1998 93 701 711 10.1046/j.1360-0443.1998.9357016.x 9692269
16. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. D Zador S Sunjic S Darke, Med J Aust 1996 164 204 207 8604187
17. The distribution of naloxone to heroin users. S Darke W Hall, Addiction 1997 92 1195 1199 10.1111/j.1360-0443.1997.tb03681.x 9374020
18. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? SR Lenton KM Hargreaves, Med J Aust 2000 173 260 263 11130352
19. Heroin overdose: the case for take-home naloxone. J Strang S Darke W Hall M Farrell R Ali, Bmj 1996 312 1435 1436 8664611
20. Heroin overdose: research and evidence-based intervention. S Darke W Hall, J Urban Health 2003 80 189 200 12791795
21. Fatal heroin 'overdose': a review. S Darke D Zador, Addiction 1996 91 1765 1772 10.1111/j.1360-0443.1996.tb03800.x 8997759
22. Acute heroin overdose. KA Sporer, Ann Intern Med 1999 130 584 590 10189329
23. Overdosing among young injection drug users in San Francisco. KC Ochoa JA Hahn KH Seal AR Moss, Addict Behav 2001 26 453 460 10.1016/S0306-4603(00)00115- 5 11436937
24. Which drugs cause overdose among opiate users? Study of personal and witnessed overdoses. J Strang P Griffiths B Powis J Fountain S Williamson, Drug Alcohol Rev 1999 18 253 261 10.1080/09595239996383
25. Cocaine-related fatalities in New South Wales, Australia 1993-2002. S Darke S Kaye J Duflou, Drug Alcohol Depend 2005 77 107 114 10.1016/j.drugalcdep. 2004.07.004 15664712
26. Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. S Kaye S Darke, Addiction 2004 99 1315 1322 10.1111/j.1360-0443.2004.00875.x 15369570
27. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City. PO Coffin C Fuller L Vadnai S Blaney S Galea D Vlahov, J Urban Health 2003 80 288 290 12791804
28. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. S Galea N Worthington TM Piper VV Nandi M Curtis DM Rosenthal, Addict Behav 2006 31 907 912 10.1016/j.addbeh.2005.07.020 16139434
29. Circumstances of witnessed drug overdose in New York City: implications for intervention. M Tracy TM Piper D Ompad A Bucciarelli PO Coffin D Vlahov S Galea, Drug Alcohol Depend 2005 79 181 190 10.1016/j.drugalcdep.2005.01.010 16002027
30. Mortality from DAWN. Substance Abuse and Mental Health Services Administration, Rockville, MD 2004 DAWN Series D-19
31. Homicide in New York City. Cocaine use and firearms. K Tardiff PM Marzuk AC Leon CS Hirsch M Stajic L Portera N Hartwell, Jama 1994 272 43 46 10.1001/jama.272.1.43 8007078
32. KJ Rothman S Greenland, Modern Epidemiology Philadelphia, PA, Lippencott-Raven Publishers 2nd 1998
33. DG Altman, Practical Statistics for Medical Research London, Chapman and Hall 1991 611
34. SB Karch, Karch's Pathology of Drug Abuse Boca Raton, FL., CRC Press 2002
35. Cardiovascular complications of cocaine use. RA Lange LD Hillis, N Engl J Med 2001 345 351 358 10.1056/NEJM200108023450507 11484693
36. JJ Platt, Cocaine addiction. Theory, research, and treatment Cambridge, MA, Harvard Univeristy Press 1997
37. The cardiovascular effects of cocaine. LR Goldfrank RS Hoffman, Ann Emerg Med 1991 20 165 175 10.1016/S0196-0644(05)81217-X 1996800
38. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. AR Jeffcoat M Perez-Reyes JM Hill BM Sadler CE Cook, Drug Metab Dispos 1989 17 153 159 2565204
39. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. RA Lange RG Cigarroa ED Flores W McBride AS Kim PJ Wells JB Bedotto RS Danziger LD Hillis, Ann Intern Med 1990 112 897 903 1971166
40. Preventing and curtailing drug use: a review of oppoutunities for developing and delivering "route transition interventions". NG Hunt M Southwell S G. J Strang, Drug Alcohol Rev 1999 18 441 445 10.1080/09595239996310
41. [Evaluation of street facilities I, II and III in Basel]. C Ronco G Spuhler P Coda R Schopfer, Soz Praventivmed 1996 41 Suppl 1 S58 S68 10.1007/BF01318589 8693818
42. Accidental fatal drug overdoses in New York City: 1990-1992. K Tardiff PM Marzuk AC Leon L Portera N Hartwell CS Hirsch M Stajic, Am J Drug Alcohol Abuse 1996 22 135 146 8727051
43. The current New York City heroin scene. B Spunt, Subst Use Misuse 2003 38 1539 1549 10.1081/JA-120023397 14509550
44. Substance use among adults 35 years of age: prevalence, adulthood predictors, and impact of adolescent substance use. AC Merline PM O'Malley JE Schulenberg JG Bachman LD Johnston, Am J Public Health 2004 94 96 102 14713705
45. L Goldman D Ausiello, Textbook of Medicine Philadelphia, PA, Suanders 2004
46. Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study. N Worthington PT Markham S Galea D Rosenthal, Harm Reduct J 2006 3 19 16822302
47. Heroin overdose: causes and consequences. M Warner-Smith S Darke M Lynskey W Hall, Addiction 2001 96 1113 1125 10.1046/j.1360-0443.2001.96811135.x 11487418
48. Cocaine use in New South Wales, Australia, 1996-2000: 5 year monitoring of trends in price, purity, availability and use from the illicit drug reporting system. S Darke S Kaye L Topp, Drug Alcohol Depend 2002 67 81 88 10.1016/S0376-8716(02)00019-4 12062781
49. Increasing deaths from opioid analgesics in the United States. LJ Paulozzi DS Budnitz Y Xi, Pharmacoepidemiol Drug Saf 2006 15 618 627 10.1002/pds.1276 16862602